Limosilactobacillus fermentum
Selected indexed studies
- Limosilactobacillus fermentum JL-3 isolated from "Jiangshui" ameliorates hyperuricemia by degrading uric acid. (Gut Microbes, 2021) [PMID:33764849]
- Limosilactobacillus fermentum CECT5716: Clinical Potential of a Probiotic Strain Isolated from Human Milk. (Nutrients, 2023) [PMID:37432320]
- Limosilactobacillus fermentum, Current Evidence on the Antioxidant Properties and Opportunities to be Exploited as a Probiotic Microorganism. (Probiotics Antimicrob Proteins, 2022) [PMID:35467236]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Limosilactobacillus fermentum JL-3 isolated from "Jiangshui" ameliorates hyperuricemia by degrading uric acid. (2021) pubmed
- Limosilactobacillus fermentum CECT5716: Clinical Potential of a Probiotic Strain Isolated from Human Milk. (2023) pubmed
- Limosilactobacillus fermentum, Current Evidence on the Antioxidant Properties and Opportunities to be Exploited as a Probiotic Microorganism. (2022) pubmed
- Limosilactobacillus fermentum Strains as Novel Probiotic Candidates to Promote Host Health Benefits and Development of Biotherapeutics: A Comprehensive Review. (2024) pubmed
- Extracellular vesicles of Limosilactobacillus fermentum SLAM216 ameliorate skin symptoms of atopic dermatitis by regulating gut microbiome on serotonin metabolism. (2025) pubmed
- Limosilactobacillus fermentum KBL674 Alleviates Vaginal Candidiasis. (2025) pubmed
- Comparative genomics-based probiotic relevance of Limosilactobacillus fermentum KUB-D18. (2022) pubmed
- Limosilactobacillus fermentum strains MC1 and D12: Functional properties and exopolysaccharides characterization. (2024) pubmed
- Comparative Probiogenomics Analysis of Limosilactobacillus fermentum 3872. (2025) pubmed
- Limosilactobacillus fermentum-fermented ginseng improved antibiotic-induced diarrhoea and the gut microbiota profiles of rats. (2022) pubmed